NCF4: A Potential Drug Target and Biomarker for Neutrophil Function and Health

Target Name: NCF4

NCBI ID: G4689

NCF4

NCF4: A Potential Drug Target and Biomarker for Neutrophil Function and Health

Introduction

Nadph oxidase is an important cellular metabolic enzyme that plays a key role in a variety of physiological processes. Among them, neutrophils (Neutrophil) are an important part of the human immune system and play an important role in anti-infection and inflammatory responses. The activation and function regulation of neutrophils involve multiple signaling pathways, including Wnt, Notch, and NF-kappa-B. In one of the signaling pathways, the NF-kappa-B signaling pathway, the NCF4 factor plays a key role. This article will discuss the function, mechanism of action and possibility of NCF4 as a drug target and biomarker.

Functions of NCF4

NCF4 is a transcription factor and a key component of the NF-kappa-B signaling pathway. In the NF-kappa-B signaling pathway, NCF4 can activate NF-kappa-B transcriptional activity by binding to DNA-binding protein (DBP). In the NF-kappa-B signaling pathway, DBPs are divided into two categories: one is constitutive DBP, such as Pyknotin; the other is conditional DBP, such as p62. NCF4 is a conditional DBP that can bind to p62, thereby activating NF-kappa-B transcriptional activity.

During the inflammatory response, activation of NCF4 leads to the activation and accumulation of neutrophils, increasing the severity of the inflammatory response. Therefore, it is of great significance to study the mechanism of NCF4 in inflammatory response. Studies have shown that activation of NCF4 promotes the NF-kappa-B signaling pathway in the inflammatory response, leading to the release of inflammatory factors and vasodilation.

as a drug target

NCF4 plays an important role in inflammatory responses and is therefore considered a potential drug target. Currently, there are some drugs targeting NCF4 on the market, such as nicarmatine (Nicardex), which is a selective DBP antagonist that inhibits the inflammatory response by blocking the activation of NCF4. Nicamatine has good efficacy in the treatment of inflammatory joint diseases such as rheumatoid arthritis (RA) and ankylosing spondylitis (Spondyloarthritis, SA).

as biomarker

Activation of NCF4 is an important biomarker in inflammatory responses. Since the activation of NCF4 can lead to the exacerbation of inflammatory response, detecting the expression level of NCF4 can indirectly reflect the severity of inflammation. Some studies have shown that the expression level of NCF4 is significantly higher in inflammatory tissues than in normal tissues.

However, current detection methods for NCF4 still have certain limitations. Although the expression of NCF4 can be detected by immunohistochemistry, the sensitivity of detection still needs to be improved. In addition, because the mechanism of action of NCF4 in inflammatory responses is very complex, further research is needed to determine the exact role of NCF4 in inflammatory responses and to develop more precise detection methods.

in conclusion

NCF4 plays an important role in the activation and functional regulation of neutrophils. As a conditional DBP, activation of NCF4 leads to an exacerbation of inflammatory responses. Therefore, NCF4 is a potential drug target. Currently, there are already some drugs targeting NCF4 on the market, such as nicamatine. Furthermore, the expression level of NCF4 can serve as a biomarker of inflammatory response. However, current detection methods for NCF4 still need to be improved, and further research is needed to determine the exact role of NCF4 in inflammatory responses and to develop more accurate detection methods.

Protein Name: Neutrophil Cytosolic Factor 4

Functions: Component of the NADPH-oxidase, a multicomponent enzyme system responsible for the oxidative burst in which electrons are transported from NADPH to molecular oxygen, generating reactive oxidant intermediates. It may be important for the assembly and/or activation of the NADPH-oxidase complex

The "NCF4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NCF4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets